Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3-Avadel Pharmaceuticals plc

22nd Jan 2026 11:43

RNS Number : 9984P
Bank of America Merrill Lynch
22 January 2026
 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Bank of America Corporation

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

AVADEL PHARMACEUTICALS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

21/01/2026

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

 

 

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

925,745

0.950%

394,247

0.405%

(2) Cash-settled derivatives

340,292

0.349%

14,457

0.015%

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.000%

0

0.000%

Total

1,266,037

1.300%

408,704

0.420%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Purchase

218

21.5 USD

USD 0.01 common

Purchase

804

21.51 USD

USD 0.01 common

Purchase

3

21.52 USD

USD 0.01 common

Purchase

26

21.495 USD

USD 0.01 common

Purchase

255

21.49 USD

USD 0.01 common

Purchase

42

21.495239 USD

USD 0.01 common

Purchase

3

21.496667 USD

USD 0.01 common

Purchase

37

21.513244 USD

USD 0.01 common

Purchase

296

21.515 USD

USD 0.01 common

Purchase

27

21.515186 USD

USD 0.01 common

Purchase

34

21.515295 USD

USD 0.01 common

Purchase

90

21.515556 USD

USD 0.01 common

Purchase

10

21.516 USD

USD 0.01 common

Purchase

3

21.516667 USD

USD 0.01 common

Purchase

4

21.51 USD

 

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Sale

376

21.5 USD

USD 0.01 common

Sale

692

21.51 USD

USD 0.01 common

Sale

134

21.52 USD

USD 0.01 common

Sale

204

21.49 USD

USD 0.01 common

Sale

138

21.495 USD

USD 0.01 common

Sale

17

21.495295 USD

USD 0.01 common

Sale

122

21.494181 USD

USD 0.01 common

Sale

87

21.495058 USD

USD 0.01 common

Sale

81

21.495062 USD

USD 0.01 common

Sale

30

21.495334 USD

USD 0.01 common

Sale

7

21.495715 USD

USD 0.01 common

Sale

10

21.496 USD

USD 0.01 common

Sale

1542

21.496602 USD

USD 0.01 common

Sale

6

21.496667 USD

USD 0.01 common

Sale

403

21.499008 USD

USD 0.01 common

Sale

112

21.515 USD

USD 0.01 common

Sale

25

21.5152 USD

USD 0.01 common

Sale

13

21.515385 USD

USD 0.01 common

Sale

9

21.515556 USD

USD 0.01 common

Sale

714

21.51 USD

USD 0.01 common

Sale

10

21.495 USD

 

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

 USD

USD 0.01 common

Swaps

Reducing a short position

74

21.4964 USD

USD 0.01 common

Swaps

Reducing a short position

148

21.4988 USD

USD 0.01 common

Swaps

Increasing a short position

37

21.5134 USD

USD 0.01 common

Swaps

Reducing a short position

652

21.4964 USD

USD 0.01 common

Swaps

Reducing a short position

122

21.494 USD

USD 0.01 common

Swaps

Reducing a short position

816

21.4964 USD

USD 0.01 common

Swaps

Reducing a short position

237

21.4988 USD

USD 0.01 common

Swaps

Reducing a short position

18

21.4988 USD

USD 0.01 common

Swaps

Reducing a short position

25

21.4898 USD

 

 

(c) Stock-settled derivative transactions (including options)

 

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

No

 

Date of disclosure

22/01/2026

Contact name

Kamil Dziedzic

Telephone number

+353 86 168 4821

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPFLLFLQFLZBBL
FTSE 100 Latest
Value10,150.05
Change11.96